Polymorphisms in the MLL breakpoint cluster region (BCR)

[1]  T. Mok,et al.  A Phase I–II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma , 2002, Cancer.

[2]  J. Squire,et al.  The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors , 2002, Genes, chromosomes & cancer.

[3]  J. Rowley,et al.  International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy‐related myelodysplastic syndromes and acute leukemia: Overview report , 2002, Genes, chromosomes & cancer.

[4]  C. Bloomfield,et al.  11q23 balanced chromosome aberrations in treatment‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop † , 2002, Genes, chromosomes & cancer.

[5]  T. Dörk,et al.  A new type of mutation causes a splicing defect in ATM , 2002, Nature Genetics.

[6]  S. Shurtleff,et al.  Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Nowell,et al.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Pandolfo,et al.  Sticky DNA, a Self-associated Complex Formed at Long GAA·TTC Repeats in Intron 1 of the Frataxin Gene, Inhibits Transcription* , 2001, The Journal of Biological Chemistry.

[9]  J. Huret,et al.  An Atlas on Chromosomes in Hematological Malignancies. Example: 11q23 and MLL partners , 2001, Leukemia.

[10]  O. Haas,et al.  Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL , 2001, Oncogene.

[11]  V. Zoumpourlis,et al.  Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-ras gene: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas. , 2001, Cancer genetics and cytogenetics.

[12]  M. Stoneking,et al.  Phylogenetic Analysis of the Friedreich Ataxia GAA Trinucleotide Repeat , 2001, Journal of Molecular Evolution.

[13]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[14]  B. Roe,et al.  DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. , 2000, Human molecular genetics.

[15]  J. Rowley,et al.  Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Ross,et al.  Dietary flavonoids and the MLL gene: A pathway to infant leukemia? , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Y. Hayashi,et al.  MLL‐CBP fusion transcript in a therapy‐related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia , 2000 .

[18]  C. Bokemeyer,et al.  Late toxicity following curative treatment of testicular cancer. , 1999, Seminars in surgical oncology.

[19]  H. Oka,et al.  Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): Correlation with adenoma growth , 1999, The Prostate.

[20]  K. Méhes,et al.  Trinucleotide repeat polymorphism at five disease loci in mixed Hungarian population. , 1999, American journal of medical genetics.

[21]  D. Wickerham,et al.  Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  G. Morgan,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Å. Borg,et al.  CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk , 1999, British Journal of Cancer.

[24]  J. Rowley.  The role of chromosome translocations in leukemogenesis. , 1999, Seminars in hematology.

[25]  Y. Hayashi,et al.  AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). , 1999, Cancer research.

[26]  M. Cleary,et al.  MLL rearrangements in haematological malignancies: lessons from clinical and biological studies , 1999, British journal of haematology.

[27]  A. Borkhardt,et al.  A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells , 1999, Oncogene.

[28]  H. Kempski,et al.  Loss of heterozygosity and microsatellite instability at the MLL locus are common in childhood acute leukemia, but not in infant acute leukemia. , 1999, Blood.

[29]  M. Osaka,et al.  MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Pandolfo,et al.  Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia. , 1999, Molecular cell.

[31]  C. Caldas,et al.  Analysis of the region of the 5′ end of the MLL gene involved in genomic duplication events , 1999, British journal of haematology.

[32]  V. Pravica,et al.  CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. , 1999, Human immunology.

[33]  A. Hajeer,et al.  In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[34]  J. Rowley,et al.  An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. , 1998, Blood.

[35]  F. Behm,et al.  Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia , 1998, Leukemia.

[36]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[37]  B. Roe,et al.  Identification of complex genomic breakpoint junctions in the t(9;11) MLL‐AF9 fusion gene in acute leukemia , 1997 .

[38]  F. Collins,et al.  Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever , 1997, Cell.

[39]  C. Croce,et al.  Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. , 1997, Cancer research.

[40]  M. Stanulla,et al.  DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis , 1997, Molecular and cellular biology.

[41]  Y. Hayashi,et al.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. , 1997, Blood.

[42]  M. Greaves.  Aetiology of acute leukaemia , 1997, The Lancet.

[43]  R. Marschalek,et al.  Exon/intron structure of the human ALL‐1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias , 1996, British journal of haematology.

[44]  N. Zeleznik-Le,et al.  Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. , 1996, Blood.

[45]  N. Zeleznik-Le,et al.  Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases [letter] , 1995 .

[46]  J. Rowley,et al.  The human MLL gene: nucleotide sequence, homology to the Drosophila trx zinc-finger domain, and alternative splicing. , 1995, DNA and cell biology.

[47]  C. Croce,et al.  Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia. , 1995, JAMA.

[48]  C. Croce,et al.  Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. , 1994, Cancer research.

[49]  N. Heerema,et al.  Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. , 1994, Blood.

[50]  M. Welsh,et al.  Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels , 1993, Nature Genetics.

[51]  X. Estivill,et al.  Novel alleles, hemizygosity and deletions at an Alu-repeat within the neurofibromatosis type 1 (NF1) gene. , 1993, Human molecular genetics.

[52]  S. Kolvraa,et al.  Three RFLPs defining a haplotype associated with the common mutation in human medium-chain acyl-CoA dehydrogenase (MCAD) deficiency occur in Alu repeats. , 1993, American journal of human genetics.

[53]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[54]  G. Evans,et al.  A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias , 1992, Nature Genetics.

[55]  U. K. Laemmli,et al.  In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. , 1992, The EMBO journal.

[56]  G. Tosato.  Generation of Epstein‐Barr Virus (EBV)–Immortalized B Cell Lines , 1991 .

[57]  J. Mattick,et al.  'Touchdown' PCR to circumvent spurious priming during gene amplification. , 1991, Nucleic acids research.

[58]  J. Kidd,et al.  Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia. , 1987, Oncogene.

[59]  U. K. Laemmli,et al.  Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold , 1984, Cell.

[60]  Y. Hayashi,et al.  MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. , 2000, Genes, chromosomes & cancer.

[61]  C. Benham,et al.  Fatal connections: When DNA ends meet on the nuclear matrix , 2000, Journal of cellular biochemistry. Supplement.

[62]  A. Chakravarti.  Population genetics—making sense out of sequence , 1999, Nature Genetics.

[63]  J. Rowley,et al.  The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.

[64]  D. Gjerde,et al.  Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. , 1997, Genetic testing.

[65]  N. Zeleznik-Le,et al.  Therapy-related acute leukemia associated with t(11q23) after primary acute myeloid leukemia with t(8;21): a report of two cases. , 1995, Blood.

[66]  S. Mirkin,et al.  Triplex DNA structures. , 1995, Annual review of biochemistry.

[67]  J. Potter,et al.  Epidemiology of childhood leukemia, with a focus on infants. , 1994, Epidemiologic reviews.

[68]  J. Rowley,et al.  Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. , 1994, Blood.